Hello there! The eagle-eyed among you will note that we've made a small but significant change to our newsletter...


Why? We were thirsty for a more direct connection – especially as we don't get to meet you in person at conferences right now. Each week, we’ll use this space to highlight content, post breaking news, or share important community updates (if you've got something to share, email aleksandra.jones@texerepublishing.com). Below you’ll find a great update on the new therapeutic options to treat dry eye disease – I hope you enjoy reading it as much as we enjoyed preparing it.

Until next time, Aleksandra Jones, Editor.
 
CORNEA / OCULAR SURFACE
The Future of OSD?
07/28/2020 | Preeya Gupta
The technologies and treatments set to revolutionize the way we approach ocular surface disease
GLAUCOMA
Alleviating the Pressure
07/27/2020 | Maryam Mahdi
Gene therapy shows promise for glaucoma in a mouse model
 
Product Profiles
Valeda® Light Delivery System by LumiThera

Valeda Light Delivery System is the First Approved Treatment for Dry Age-Related Macular Degeneration Using Photobiomodulation. Read more
Intensity by Hanita Lenses - Vision Redefined

Intensity lens employs Dynamic Light Utilization technology for maximal light efficiency that transcends the traditional boundaries of conservative diffractive IOL patterns, bringing unprecedented vivid vision to cataract patients. Read more
 
Special Promotions
Stefano Barabino explains how the pandemic is affecting ocular surface health

Stefano Barabino, Head of the Ocular Surface Center at the Sacco Hospital in Milan, Italy, talks about the implications the COVID-19 pandemic has had for patients suffering from dry eye disease. Read more
Rheon Medical’s eyeWatch offers true pressure control in glaucoma management

André Mermoud and Leon Au talk about their impressions of the eyeWatch system, designed to drain aqueous humor in glaucoma patients, while allowing physicians to non-invasively adjust IOP. Read more
Redressing the Balance with The Power List 2021 – Nominations are OPEN!

In 2021, we will be mixing things up following calls for more female representation on The Power List!  So, to fully acknowledge the undeniable impact women have on ophthalmic clinical practice, research, education, and industry, we will feature the Top 50 Women in Ophthalmology.
Vote Now!
 
Interested in Conferences and Events?

We work with event organizers from all around the world to help bring the ophthalmologic community together, from flagship congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and stay up-to-date with the latest developments.
Find out more
This email was sent to {~email~} by info@theophthalmologist.com. To ensure delivery of emails to your inbox, please add info@theophthalmologist.com to your address book or safe sender list. To view online, please click here.

Create or manage your account here
Unsubscribe here

The Ophthalmologist is a brand of Texere Publishing Limited

Texere Publishing Limited, Booths Park 1,
Chelford Road, Knutsford, WA16 8GS, UK
Registered Company Number: 08113419
Texere Publishing Inc., 115 Broadway, FL 5,
New York, NY 10006, USA
Federal Identification Number: 81-4613586